MannKind Corporation (MNKD) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of MannKind Corporation and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MNKD
MannKind Corporation
$3.71HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$11.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MNKD vs ORIC
growth of $100 · dividends reinvested · last 6yMNKD +210.6% (+20.8%/yr)ORIC -51.5% (-11.4%/yr)MNKD compounded faster over this window
Log scale — wide-divergence pair
MNKD ORIC
MNKD vs ORIC: by the numbers
- •ORIC is the larger company ($1.24B vs $1.18B market cap).
- •Both run net losses; ORIC's is the smaller (0.00% vs -11.08% net margin).
Metrics side by side
Valuation
| Metric | MNKD | ORIC |
|---|---|---|
| P/S ratio | 3.01 | N/A |
| P/B ratio | N/A | 3.25 |
| EV / EBITDA | 51.23 | N/A |
Profitability
| Metric | MNKD | ORIC |
|---|---|---|
| Gross margin | 75.69% | 0.00% |
| Operating margin | 11.12% | 0.00% |
| Net margin | -11.08% | 0.00% |
| ROE | N/A | -36.81% |
| ROIC | 1.32% | -40.32% |
Growth (annualized)
| Metric | MNKD | ORIC |
|---|---|---|
| Revenue CAGR (5Y) | 39.51% | N/A |
| Total return CAGR (5Y) | -4.18% | -8.73% |
Frequently asked
- How have MNKD and ORIC total returns compared?
- Over the past 5 years, MNKD delivered -4.18% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MannKind ROEORIC Pharmaceuticals ROEMannKind operating marginORIC Pharmaceuticals operating marginMannKind revenue growthORIC Pharmaceuticals revenue growthMannKind free cash flowORIC Pharmaceuticals free cash flow
MannKind & ORIC Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.